BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 11441025)

  • 21. Fibrillar collagen regulation of plasminogen activator inhibitor-1 is involved in altered smooth muscle cell migration.
    Tanaka S; Koyama H; Ichii T; Shioi A; Hosoi M; Raines EW; Nishizawa Y
    Arterioscler Thromb Vasc Biol; 2002 Oct; 22(10):1573-8. PubMed ID: 12377732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metastasis of transgenic breast cancer in plasminogen activator inhibitor-1 gene-deficient mice.
    Almholt K; Nielsen BS; Frandsen TL; Brünner N; Danø K; Johnsen M
    Oncogene; 2003 Jul; 22(28):4389-97. PubMed ID: 12853975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Both u-PA inhibition and vitronectin binding by plasminogen activator inhibitor 1 regulate HT1080 fibrosarcoma cell metastasis.
    Praus M; Collen D; Gerard RD
    Int J Cancer; 2002 Dec; 102(6):584-91. PubMed ID: 12447999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Role of plasminogen activator inhibitor type 1 in tumor angiogenesis].
    Bajou K; Devy L; Masson V; Albert V; Frankenne F; Noël A; Foidart JM
    Therapie; 2001; 56(5):465-72. PubMed ID: 11806282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nicotine induces cyclooxygenase-2 and vascular endothelial growth factor receptor-2 in association with tumor-associated invasion and angiogenesis in gastric cancer.
    Shin VY; Wu WK; Chu KM; Wong HP; Lam EK; Tai EK; Koo MW; Cho CH
    Mol Cancer Res; 2005 Nov; 3(11):607-15. PubMed ID: 16317086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel function of plasminogen activator inhibitor-1 in modulation of the AKT pathway in wild-type and plasminogen activator inhibitor-1-deficient endothelial cells.
    Balsara RD; Castellino FJ; Ploplis VA
    J Biol Chem; 2006 Aug; 281(32):22527-36. PubMed ID: 16785241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Roles of urokinase type plasminogen activator in a brain stab wound.
    Kataoka K; Asai T; Taneda M; Ueshima S; Matsuo O; Kuroda R; Kawabata A; Carmeliet P
    Brain Res; 2000 Dec; 887(1):187-90. PubMed ID: 11134604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dose-dependent modulation of choroidal neovascularization by plasminogen activator inhibitor type I: implications for clinical trials.
    Lambert V; Munaut C; Carmeliet P; Gerard RD; Declerck PJ; Gils A; Claes C; Foidart JM; Noël A; Rakic JM
    Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2791-7. PubMed ID: 12766088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of plasminogen activator inhibitor type 1 by human prostate carcinoma cells inhibits primary tumor growth, tumor-associated angiogenesis, and metastasis to lung and liver in an athymic mouse model.
    Soff GA; Sanderowitz J; Gately S; Verrusio E; Weiss I; Brem S; Kwaan HC
    J Clin Invest; 1995 Dec; 96(6):2593-600. PubMed ID: 8675623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasminogen activator inhibitor-1 as a measure of vascular remodelling in breast cancer.
    Fox SB; Taylor M; Grøndahl-Hansen J; Kakolyris S; Gatter KC; Harris AL
    J Pathol; 2001 Sep; 195(2):236-43. PubMed ID: 11592104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of tissue-type plasminogen activator and its inhibitor couples with development of capillary network by human microvascular endothelial cells on Matrigel.
    Ito K; Ryuto M; Ushiro S; Ono M; Sugenoya A; Kuraoka A; Shibata Y; Kuwano M
    J Cell Physiol; 1995 Feb; 162(2):213-24. PubMed ID: 7822431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting tumor angiogenesis with histone deacetylase inhibitors: the hydroxamic acid derivative LBH589.
    Qian DZ; Kato Y; Shabbeer S; Wei Y; Verheul HM; Salumbides B; Sanni T; Atadja P; Pili R
    Clin Cancer Res; 2006 Jan; 12(2):634-42. PubMed ID: 16428510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination angiostatin and endostatin gene transfer induces synergistic antiangiogenic activity in vitro and antitumor efficacy in leukemia and solid tumors in mice.
    Scappaticci FA; Smith R; Pathak A; Schloss D; Lum B; Cao Y; Johnson F; Engleman EG; Nolan GP
    Mol Ther; 2001 Feb; 3(2):186-96. PubMed ID: 11237675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gabexate mesilate inhibits colon cancer growth, invasion, and metastasis by reducing matrix metalloproteinases and angiogenesis.
    Yoon WH; Jung YJ; Kim TD; Li G; Park BJ; Kim JY; Lee YC; Kim JM; Park JI; Park HD; No ZS; Lim K; Hwang BD; Kim YS
    Clin Cancer Res; 2004 Jul; 10(13):4517-26. PubMed ID: 15240544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumoral and choroidal vascularization: differential cellular mechanisms involving plasminogen activator inhibitor type I.
    Jost M; Maillard C; Lecomte J; Lambert V; Tjwa M; Blaise P; Alvarez Gonzalez ML; Bajou K; Blacher S; Motte P; Humblet C; Defresne MP; Thiry M; Frankenne F; Gothot A; Carmeliet P; Rakic JM; Foidart JM; Noël A
    Am J Pathol; 2007 Oct; 171(4):1369-80. PubMed ID: 17717143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibodies to PAI-1 alter the invasive and migratory properties of human tumour cells in vitro.
    Brooks TD; Slomp J; Quax PH; De Bart AC; Spencer MT; Verheijen JH; Charlton PA
    Clin Exp Metastasis; 2000; 18(6):445-53. PubMed ID: 11592301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. XR5967, a novel modulator of plasminogen activator inhibitor-1 activity, suppresses tumor cell invasion and angiogenesis in vitro.
    Brooks TD; Wang SW; Brünner N; Charlton PA
    Anticancer Drugs; 2004 Jan; 15(1):37-44. PubMed ID: 15090742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperthermia inhibits angiogenesis by a plasminogen activator inhibitor 1-dependent mechanism.
    Roca C; Primo L; Valdembri D; Cividalli A; Declerck P; Carmeliet P; Gabriele P; Bussolino F
    Cancer Res; 2003 Apr; 63(7):1500-7. PubMed ID: 12670896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interferon γ and plasminogen activator inhibitor 1 regulate adhesion formation after partial hepatectomy.
    Ohashi K; Yoshimoto T; Kosaka H; Hirano T; Iimuro Y; Nakanishi K; Fujimoto J
    Br J Surg; 2014 Mar; 101(4):398-407. PubMed ID: 24536011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant PAI-1 inhibits angiogenesis and reduces size of LNCaP prostate cancer xenografts in SCID mice.
    Swiercz R; Keck RW; Skrzypczak-Jankun E; Selman SH; Jankun J
    Oncol Rep; 2001; 8(3):463-70. PubMed ID: 11295064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.